Which mutual funds hold Orchid Pharma?
26 Direct Growth mutual fund schemes held Orchid Pharma (Healthcare) at the end of Aug 2026, 1 fewer than in Jul 2026. The largest position was in Kotak Special Opportunities Fund, at 2.72% of the scheme.
- Schemes holding
- 26
- New entries
- 0
- Fully exited
- 1
- Increased
- 3
- Decreased
- 5
- Average weight
- 0.68%
By fund type: Equity 18 · Hybrid 6 · Index 2
What changed in Aug 2026
vs Jul 2026 · by number of sharesFully exited (1)
- Kotak Services Fund Sectoral / Thematic0.13%
Increased (3)
- Kotak Special Opportunities Fund Sectoral / Thematic2.85% → 2.72%
- UTI Small Cap Fund Small Cap0.82% → 0.91%
- WhiteOak Capital Pharma and Heathcare Fund Sectoral / Thematic0.27% → 0.41%
Decreased (5)
- Bandhan Healthcare Fund Sectoral / Thematic1.70% → 1.08%
- Bandhan Multi Cap Fund Multi Cap0.48% → 0.32%
- UTI Conservative Hybrid Fund Conservative Hybrid0.31% → 0.30%
- Bandhan Multi Asset Allocation Fund Multi Asset Allocation0.34% → 0.16%
- Bandhan BSE Healthcare Index Fund Equity Index0.09% → 0.09%
Weight shown as last month → this month. Only the 1,622 schemes with portfolios for both months are compared.
All 26 schemes holding Orchid Pharma
Sorted by weight in the scheme| # | Scheme | Category | Weight | Shares | This month |
|---|---|---|---|---|---|
| 1 | Kotak Special Opportunities Fund Kotak Mahindra | Sectoral / Thematic | 2.72% | 4,77,811 | Increased |
| 2 | Kotak Healthcare Fund Kotak Mahindra | Sectoral / Thematic | 1.64% | 1,30,000 | Unchanged |
| 3 | Kotak Consumption Fund Kotak Mahindra | Sectoral / Thematic | 1.60% | 2,86,000 | Unchanged |
| 4 | UTI Value Fund UTI | Value | 1.22% | 12,00,000 | Unchanged |
| 5 | Kotak MNC Fund Kotak Mahindra | Sectoral / Thematic | 1.09% | 2,60,000 | Unchanged |
| 6 | Bandhan Healthcare Fund Bandhan | Sectoral / Thematic | 1.08% | 37,000 | Decreased |
| 7 | Tata India Innovation Fund Tata | Sectoral / Thematic | 1.04% | 1,44,093 | Unchanged |
| 8 | quant | Small Cap | 0.95% | 34,65,947 | Unchanged |
| 9 | UTI Small Cap Fund UTI | Small Cap | 0.91% | 5,09,966 | Increased |
| 10 | PGIM India Healthcare Fund PGIM India | Sectoral / Thematic | 0.80% | 10,285 | Unchanged |
| 11 | PGIM India Small Cap Fund PGIM India | Small Cap | 0.76% | 1,40,765 | Unchanged |
| 12 | UTI Healthcare Fund UTI | Sectoral / Thematic | 0.68% | 1,01,402 | Unchanged |
| 13 | Kotak Multi Asset Allocation Fund Kotak Mahindra | Multi Asset Allocation | 0.60% | 9,42,962 | Unchanged |
| 14 | Invesco India Contra Fund Invesco | Contra | 0.47% | 9,90,763 | Unchanged |
| 15 | WhiteOak Capital Pharma and Heathcare Fund WhiteOak Capital | Sectoral / Thematic | 0.41% | 37,747 | Increased |
| 16 | Invesco India Equity Savings Fund Invesco | Equity Savings | 0.37% | 10,564 | Unchanged |
| 17 | Bandhan Multi Cap Fund Bandhan | Multi Cap | 0.32% | 1,00,000 | Decreased |
| 18 | UTI Conservative Hybrid Fund UTI | Conservative Hybrid | 0.30% | 51,000 | Decreased |
| 19 | Invesco | Small Cap | 0.28% | 4,55,183 | Unchanged |
| 20 | Bandhan Multi Asset Allocation Fund Bandhan | Multi Asset Allocation | 0.16% | 60,000 | Decreased |
| 21 | Bandhan | Small Cap | 0.13% | 4,43,891 | Unchanged |
| 22 | Bandhan BSE Healthcare Index Fund Bandhan | Equity Index | 0.09% | 196 | Decreased |
| 23 | Kotak Mahindra | Multi Cap | 0.08% | 2,64,308 | Unchanged |
| 24 | Bandhan Balanced Advantage Fund Bandhan | Balanced Advantage | 0.01% | 2,848 | Unchanged |
| 25 | Kotak Mahindra | Balanced Advantage | 0.01% | 24,712 | Unchanged |
| 26 | Motilal Oswal BSE 1000 Index Fund Motilal Oswal | Equity Index | 0.01% | 45 | Unchanged |
Explore Orchid Pharma changes →What funds bought and sold this month →All stocks A–Z →
Want to know what this means for your portfolio?
Owning Orchid Pharma through several funds at once is common — and easy to miss. Sulekha Sen can check what your funds really hold and whether it fits your goals.
Book a free 30-min call →Data: each AMC’s SEBI-mandated monthly portfolio disclosure, Aug 2026 (compared with Jul 2026). Holdings change after month-end. Direct Plan – Growth schemes only; one row per scheme. Changes are measured by number of shares or units, not portfolio weight. Not investment advice, and not a recommendation to buy, sell or hold any security or scheme. Mutual fund investments are subject to market risks, read all scheme related documents carefully.